Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04119063
Other study ID # 986744
Secondary ID 1R15HD099664-01
Status Completed
Phase Early Phase 1
First received
Last updated
Start date September 8, 2019
Est. completion date November 20, 2022

Study information

Verified date January 2024
Source Northern Arizona University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overarching goal of this study is to improve mobility in individuals with movement disorders through advances in wearable assistance (i.e. powered orthoses).


Description:

Individuals with cerebral palsy completed high frequency over-ground gait training (4x/week for 1 week) with ankle exoskeleton assistance, and then, after a 1 year washout period, the same participants will complete low frequency over-ground gait training (2x/week for 2 weeks).


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date November 20, 2022
Est. primary completion date November 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 35 Years
Eligibility Inclusion Criteria: - Age between 5 and 35 years old, inclusive. - Either a healthy volunteer or a diagnosis of a neurologically-based walking disorder due to stroke, spinal cord injury, Parkinson's disease, or cerebral palsy. - Must be able to understand and follow simple directions based on parent report and clinical observation during the history and physical examination. - Able to provide verbal assent, if appropriate. If the participant is non-verbal, parental interpretation of gesticulation for assent will be used. - The ability to read and understand English. - Able to walk at least 30 feet with or without a walking aid (GMFCS Level I-III for individuals with cerebral palsy) Exclusion Criteria: • Any neurological, musculoskeletal or cardiorespiratory injury, health condition ( including pregnancy), or diagnosis other than stroke, spinal cord injury, Parkinson's disease or cerebral palsy that would affect the ability to walk as directed for short periods of time.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
powered orthosis
Novel powered leg brace to provide assistance during walking.

Locations

Country Name City State
United States Northern Arizona University Flagstaff Arizona

Sponsors (2)

Lead Sponsor Collaborator
Northern Arizona University Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Metabolic Energy Required to Walk The change in the metabolic energy required to walk will be measured using a portable metabolic measurement system (Cosmed K5). Units: change in % difference post vs pre gait training. Measured at the pre (day 1) and post (day 4) gait training assessments
Primary Change in Walking Speed The change in the walking speed will be measured over-ground using a stop watch. Units: % change between post vs pre assessments Measured at the pre (day 1) and post (day 4) gait training assessments
Secondary Change in Stride Length The change in the stride length will be measured by dividing the number of steps by distance traveled. Units: % change between post vs pre assessments. Measured at the pre (day 1) and post (day 4) gait training assessments
Secondary Change in Cadence The change in the number of steps taken per minute will be measured using a counter. Units: % change between post vs pre assessments. Measured at the pre (day 1) and post (day 4) gait training assessments
Secondary Change in Muscle Activity Variance Ratio The change in the muscle activity variance ratio of the soleus during walking will be measured using electromyography electrodes. Units: % change between post vs pre assessments. Measured at the pre (day 1) and post (day 4) gait training assessments
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2
Completed NCT02849938 - Evaluating the Value of Telehealth for Care of Children With Medical Complexity N/A
Completed NCT02897024 - A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE) N/A